Keros Therapeutics (KROS)

130 institutional managers hold KROS in their latest 13F filings. Search all 13F filers on SECspotter.

© 2026 SECspotter. Holdings come from Form 13F filings on SEC EDGAR. Some tickers and fund names come from issuers’ and exchanges’ public records, and share counts marked ~ are estimated from the reported value. SECspotter is not affiliated with or endorsed by the U.S. Securities and Exchange Commission. CUSIP® is a registered trademark of the American Bankers Association.